Low-Dose Atropine Shows Promise for Myopia Control in Children

Myopia, commonly known as nearsightedness, is becoming increasingly prevalent among children worldwide. The condition typically develops during school years and can progress rapidly, leading to high myopia that increases the risk of serious eye conditions later in life. ## What the Research Shows A landmark multi-center clinical trial published in early 2026 has confirmed what smaller studies suggested: low-dose atropine eye drops (0.01% to 0.05% concentration) can slow myopia progression by 50-60% in children aged 6-12 years. The study followed over 2,000 children across 15 countries for three years, making it one of the largest and most comprehensive myopia control trials ever conducted. ## How Atropine Works Atropine is a medication that has been used in ophthalmology for decades. At higher concentrations, it dilates the pupil and temporarily paralyzes the focusing muscle of the eye. However, at the very low doses used for myopia control: - **Minimal side effects** — Unlike full-strength atropine, low-dose formulations cause negligible pupil dilation and minimal light sensitivity - **Simple administration** — One drop in each eye before bedtime - **Long-term safety** — The three-year study showed no significant adverse effects ## What This Means for Parents in Dushanbe If your child has been diagnosed with myopia and you've noticed their prescription getting stronger each year, low-dose atropine therapy may be worth discussing with your ophthalmologist. Key factors to consider: 1. **Age matters** — The treatment is most effective when started early, ideally between ages 6-12 2. **Not a cure** — Atropine slows progression but doesn't reverse existing myopia 3. **Combined approach** — Best results come from combining atropine with outdoor time (at least 2 hours daily) and proper screen habits 4. **Regular monitoring** — Children on atropine therapy need check-ups every 3-6 months ## Dr. Karimova's Perspective At our clinic in Dushanbe, we're seeing the same global trend — more children developing myopia at younger ages, often linked to increased screen time and reduced outdoor activity. Low-dose atropine is an exciting addition to our toolkit for managing childhood myopia. If you're concerned about your child's vision, I recommend scheduling a comprehensive eye examination. Early detection and intervention give us the best chance of protecting your child's long-term eye health. --- *Schedule an appointment at our clinic on Bekhzod Street 14, inside Osse Optical. Call [+992 108 11 80 80](tel:+992108118080).*